Cargando…
Evaluation of the risk of acute kidney injury with the use of piperacillin/tazobactam among adult critically ill patients
PURPOSE: Piperacillin/tazobactam (PT), when combined with vancomycin, is associated with an increased risk of acute kidney injury (AKI). It is not known whether PT alone is associated with a higher incidence of AKI compared to other β-lactams among critically ill patients. The objective of this stud...
Autores principales: | Saad, Mohamed O., Mohamed, Adham M., Mitwally, Hassan A., Shible, Ahmed A., Ait Hssain, Ali, Abdelaty, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518983/ https://www.ncbi.nlm.nih.gov/pubmed/32700095 http://dx.doi.org/10.1007/s15010-020-01480-x |
Ejemplares similares
-
Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients
por: Felton, T W, et al.
Publicado: (2014) -
1555. Risk of Developing Acute Kidney Injury in Patients Receiving Piperacillin–Tazobactam and Vancomycin Compared with Those on Piperacillin–Tazobactam and Telavancin
por: Reilly, Joseph, et al.
Publicado: (2019) -
Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
por: Selig, Daniel J., et al.
Publicado: (2022) -
We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
por: Cotta, Menino Osbert, et al.
Publicado: (2016) -
EVALUATION OF HYDROCORTISONE, VITAMIN C, AND THIAMINE FOR THE TREATMENT OF SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL (THE HYVITS TRIAL)
por: Mohamed, Adham, et al.
Publicado: (2023)